UnitedHealth Group Incorporated $UNH Position Increased by Foundations Investment Advisors LLC

Foundations Investment Advisors LLC increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 12.2% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 61,046 shares of the healthcare conglomerate’s stock after buying an additional 6,655 shares during the period. Foundations Investment Advisors LLC’s holdings in UnitedHealth Group were worth $19,045,000 as of its most recent filing with the SEC.

Several other institutional investors also recently made changes to their positions in UNH. Prospect Financial Services LLC bought a new stake in UnitedHealth Group in the second quarter valued at $235,000. Islay Capital Management LLC acquired a new position in UnitedHealth Group during the 2nd quarter valued at about $31,000. Davis Selected Advisers raised its holdings in shares of UnitedHealth Group by 2,234.9% during the second quarter. Davis Selected Advisers now owns 1,132,885 shares of the healthcare conglomerate’s stock valued at $353,426,000 after buying an additional 1,084,366 shares during the last quarter. WP Advisors LLC increased its position in UnitedHealth Group by 259.2% in the 2nd quarter. WP Advisors LLC now owns 18,303 shares of the healthcare conglomerate’s stock valued at $5,710,000 after acquiring an additional 13,208 shares during the period. Finally, Hibernia Wealth Partners LLC bought a new position in shares of UnitedHealth Group in the second quarter worth $207,000. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $321.44 on Friday. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $622.83. The stock has a market cap of $291.17 billion, a PE ratio of 16.78, a price-to-earnings-growth ratio of 2.28 and a beta of 0.47. The company has a quick ratio of 0.85, a current ratio of 0.82 and a debt-to-equity ratio of 0.71. The business has a fifty day simple moving average of $347.65 and a 200-day simple moving average of $320.06.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The company had revenue of $113.16 billion for the quarter, compared to the consensus estimate of $113.19 billion. During the same quarter in the prior year, the company earned $7.15 EPS. The firm’s quarterly revenue was up 12.2% on a year-over-year basis. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 16th. Investors of record on Monday, December 8th will be given a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a yield of 2.8%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 46.14%.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the stock. TD Cowen increased their target price on shares of UnitedHealth Group from $335.00 to $338.00 and gave the company a “hold” rating in a research report on Thursday, October 30th. Jefferies Financial Group upped their target price on UnitedHealth Group from $317.00 to $409.00 and gave the stock a “buy” rating in a research report on Friday, October 17th. UBS Group boosted their price objective on UnitedHealth Group from $378.00 to $430.00 and gave the stock a “buy” rating in a research note on Wednesday, October 29th. Baird R W downgraded shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a report on Thursday, July 31st. Finally, Truist Financial boosted their target price on shares of UnitedHealth Group from $310.00 to $365.00 and gave the stock a “buy” rating in a report on Tuesday, September 9th. Eighteen analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $397.12.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.